# Bioequivalence Study of Zonisamide Capsules 100 mg of Dr.Reddy's Laboratories Limited Under Fasting Conditions

> **NCT01161966** · PHASE1 · COMPLETED · sponsor: **Dr. Reddy's Laboratories Limited** · enrollment: 26 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Zonisamide
- **DRUG:** Zonegran

## Key facts

- **NCT ID:** NCT01161966
- **Lead sponsor:** Dr. Reddy's Laboratories Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-01
- **Primary completion:** 2005-02
- **Final completion:** 2005-03
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2010-07-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01161966

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01161966, "Bioequivalence Study of Zonisamide Capsules 100 mg of Dr.Reddy's Laboratories Limited Under Fasting Conditions". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01161966. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*